Table 2 Clinical and laboratory characteristics.
From: Prognosis of alcohol-associated lactic acidosis in critically ill patients: an 8-year study
Characteristics | Values (N = 23) | ||
|---|---|---|---|
n (%) | Median/IRQ | mean ± SD | |
Age (years) | 51.0/10.0 | 50.0 ± 10.9 | |
APACHE II score | 14.0/9.0 | 15.5 ± 6.7 | |
Peak lactate level (mmol/L) | 15.9/8.2 | 17.9 ± 7.0 | |
Nadir arterial pH | 7.25/0.34 | 7.18 ± 0.21 | |
Nadir arterial bicarbonate level (mmol/L) | 8.7/11.3 | 9.5 ± 5.8 | |
Sex, male, (%) | 22 (95.7%) | ||
Positive blood or urine ketone body, n (%) (N = 20) | 15 (75.0%*) | ||
Positive serum alcohol level, n (%) (N = 14) | 10 (71.4%$) | ||
Hypoglycemia, n (%) | 2 (8.7%) | ||
Hyperammonemia, n (%) | 17 (73.9%) | ||
High MCV, n (%) | 14 (60.9%) | ||
Gastrointestinal bleeding, n (%) | 5 (21.7%) | ||
Sepsis, n (%) | 11 (47.8%) | ||
Acute kidney injury, n (%) | 16 (69.6%) | ||
Chronic kidney disease, n (%) | 2 (8.7%) | ||
Liver cirrhosis, n (%) | 9 (39.1%) | ||
Hepatitis, n (%) | 4 (17.4%) | ||
Need of vasoactive support, n (%) | 3 (13.0%) | ||
Need of ventilator support, n (%) | 2 (8.7%) | ||
Need of renal replacement therapy, n (%) | 1 (4.3%) | ||
